To test whether transient receptor potential channel vanilloid subfamily member-1 (TRPV1) mediates acid-induced inflammation in the esophagus, a tubular segment of esophageal mucosa was tied at both ends, forming a sac. The sac was filled with 0.01 N HCl (or Krebs buffer for control) and kept in oxygenated Krebs buffer at 37°C. The medium around the sac (supernatant) was collected after 3 h. Supernatant of the HCl-filled sac abolished contraction of esophageal circular muscle strips in response to electric field stimulation. Contraction was similarly abolished by supernatant of mucosal sac filled with the TRPV1 agonist capsaicin (10 Ϫ6 M). These effects were reversed by the selective TRPV1 antagonist 5Ј-iodoresiniferatoxin (IRTX) and by the plateletactivating factor (PAF) receptor antagonist CV9388. Substance P and CGRP levels in mucosa and in supernatant increased in response to HCl, and these increases were abolished by IRTX and by tetrodotoxin (TTX) but not affected by CV9388, indicating that substance P and CGRP are neurally released and PAF independent. In contrast, the increase in PAF was blocked by IRTX but not by TTX. Presence of TRPV1 receptor was confirmed by RT-PCR and by Western blot analysis in whole mucosa and in esophageal epithelial cells enzymatically isolated and sorted by flow cytometry or immunoprecipitated with cytokeratin antibodies. In epithelial cells PAF increased in response to HCl, and the increase was abolished by IRTX. We conclude that HCl-induced activation of TRPV1 receptors in esophageal mucosa causes release of substance P and CGRP from neurons and release of PAF from epithelial cells. smooth muscle; signal transduction; platelet-activating factor TRANSIENT RECEPTOR POTENTIAL channel vanilloid subfamily member-1 (TRPV1, also known as VR1) was originally described in primary sensory neurons as a receptor for capsaicin and related natural irritants (collectively referred to as vanilloids) (61). TRPV1 is a nonselective cation channel expressed by several cell types including sensory nerves. It is activated by heat, by the pungent ingredient of chili peppers, capsaicin, or by endogenous hydrogen ions released in tissues during inflammation (61) or present in gastric reflux. TRPV1 is now believed to function as a molecular integrator of noxious stimuli, including acids, heat, pollutants with negative electric charge, and endogenous proinflammatory substances (23). TRPV1 activation in primary afferent neurons evokes the sensation of burning pain and induces neurogenic inflammation by the release of substance P and calcitonin gene-related peptide (CGRP) (65, 66). Upregulated TRPV1 expression has been demonstrated in disease states such as inflammatory bowel disease (66) and irritable bowel syndrome (15) and, more recently, in esophageal submucosal neurons of esophagitis patients (5, 41).
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TRPV1-associated "neurogenic inflammation" has been examined in several systems, particularly in the airways, and to a lesser extent in the digestive tract. In the digestive tract most publications have focused on the role of vanilloid receptor in inflammation, with emphasis on stimulation of substance P release (36 -40, 42-44, 46, 47) or on a role of endopeptidases in degradation of substance P, with a resulting decrease in inflammation (1, 35, 60) . In the ileum and colon, TRPV1 is thought to be a mediator of inflammation because in experimental models of colitis induced by dextran sulfate sodium (DSS) (33, 34) or of ileitis induced by Clostridium difficile toxin A (43) or anandamide (42) attenuation of colitis occurs in response to TRPV1 channel blockers (33, 34) or after genetic deletion of TRPV1 (28) .
To test whether this acid-sensitive receptor may be the initial mediator of acid-induced inflammation in the esophagus, we recently developed an experimental model (20) in which a tubular segment of normal esophageal mucosa is removed from the cat esophagus and tied at both ends to form a mucosal sac. The sac is filled with Krebs buffer equilibrated with HCl to pH 5.8 (or with normal Krebs solution for control) and kept in oxygenated Krebs solution at 37°C. The medium around the HCl-filled sac (supernatant) is collected after 3-h incubation and applied to circular muscle strips or examined for inflammatory mediator content (20) .
With this model we found that acid-induced activation of TRPV1 receptors in esophageal mucosa results in release of substance P and CGRP, presumably arising from intrinsic submucous neurons, and in release of platelet-activating factor (PAF), most likely originating from esophageal epithelial cells.
METHODS
Tissue preparation. Experimental procedures were approved by the Animal Welfare Committee of Rhode Island Hospital. Adult male cats weighing between 3.5 and 5.5 kg were used in this study. After an overnight fast, animals were initially anesthetized with ketamine (Aveco, Fort Dodge, IA) and then euthanized with an overdose of phenobarbital (Schering, Kenilworth, NJ). The chest and abdomen were opened with a midline incision, exposing the esophagus and stomach. The esophagus and stomach were removed together and separated immediately above the lower esophageal sphincter (LES). The esophagus was pinned on a wax block, and the smooth muscle layer was opened along the long axis and removed by sharp microdissection at the level of the submucosa, leaving the mucosa intact as a tube and taking care to keep the submucosa in its entirety with the mucosa preparation. The remaining smooth muscle layer was cut into 2-mm circular muscle strips, which were mounted in separate 1-ml muscle chambers and used for electrical field stimulation (EFS), as previously described in detail (6) . The esophageal mucosal tube consisted of epithelial cells, lamina propria, muscularis mucosae, and submucosa, including submucosal and lamina propria neurons (10, 25, 31, 49, 50, 53, 56, 59, 62) , with the epithelial layer on the inside. The separation between mucosal sac and circular muscle strips was as close to the inner layer of the circular muscle as could be surgically achieved under the dissecting microscope; thus the sac included the submucosa, and it seems reasonable that whatever came out of the sac into the supernatant would directly affect the muscle layer. The esophageal mucosa tube was divided in two parts, and each part was tied at both ends. One, chosen at random, was filled with Krebs buffer (0.5 ml/cm of tube) and used as a control; the other was filled with the same volume of Krebs buffer equilibrated with HCl to pH 5.8. We have shown (20) that in the mucosa tissue content of IL-1␤ and IL-6 was highest when the sac was filled with medium at a pH between 5.8 and 4.8 and declined when the pH was lowered to 4, likely reflecting tissue damage.
Both tubes were kept in Krebs buffer with 95% O2-5% CO2 at 36°C for 3 h, with 1 ml of Krebs buffer per 100 mg of mucosa. The pH of the supernatant remained at 7.4 and needed no adjustment. After 3 h, the supernatant surrounding the tubes was collected and analyzed or used to examine its effect on muscle contraction. The mucosa tubes were then opened, the luminal content was discarded, and the tissue was used to measure cytokine content. This experimental preparation has been described in detail previously (20) .
Histopathological studies. Cross-sectional segments of esophagus were immersion fixed in Histochoice (Amresco, Solon, OH) and embedded in paraffin as previously described (22) . Paraffin-embedded histological sections were dewaxed in xylenes, rehydrated through graded alcohol solutions, and then equilibrated in Tris-buffered saline (TBS; 100 mM Tris, 150 mM NaCl, pH 7.6). Alternate segments were snap-frozen in a dry ice methanol bath, and cryostat sections were fixed in Histochoice and then equilibrated in TBS. Adjacent histological sections (5 m thick) were used for immunohistochemical staining to detect substance P (Santa Cruz) or CGRP (Santa Cruz). First, endogenous peroxidase activity was quenched by a 30-min incubation in 3% H2O2 in 60% methanol. Nonspecific binding sites were adsorbed by a 30-min incubation in 1% normal goat ϩ normal rabbit serum prepared in TBS with 0.05% Tween 20, pH 7.6 (TBST). Sections were then incubated with 1 g/ml of anti-substance P or anti-CGRP DNA antibody overnight at 4°C in a humidified chamber. Immunoreactivity was detected with horseradish peroxidase (HRP)-conjugated polymer-tagged secondary antibodies (Abcam, Cambridge, MA) and diaminobenzidine as the chromagen. The sections were lightly counterstained with hematoxylin. Tissue sections were preserved under cover glass and examined by light microscopy. Between steps, the slides were rinsed three times, 2 min each, in 250 ml of TBST with gentle platform agitation.
Measurements of contraction. Circular muscle strips devoid of mucosa (2 mm wide) were mounted in separate 1-ml muscle chambers as described in detail elsewhere (6) . They were initially stretched to 2.5 g to bring them near conditions of optimum force development and equilibrated for 2 h while being perfused continuously with oxygenated physiological salt solution (PSS) at 37°C. The PSS contained the following (in mmol/l): 116.6 NaCl, 21.9 NaHCO3, 1.2 KH2PO4, 3.4 KCl, 2.5 CaCl2, 5.4 glucose, and 1.2 MgCl2. The solution was equilibrated with a gas mixture containing 95% O2 and 5% CO2 at 37°C, pH 7.4. After equilibration, esophageal strips were stimulated with EFS consisting of 10-s trains of square-wave pulses of supramaximal voltage (0.2-ms duration at 0.5-5 Hz). The stimuli were delivered by a stimulator (model S48; Grass Instruments, West Warwick, RI) through platinum wire electrodes placed longitudinally on either side of the strip, resulting in contractions of 4-to 6-g force for maximally stimulated control strips.
To study the effect of supernatant from HCl-treated or capsaicintreated mucosa on EFS-induced contraction, 0.1-0.15 ml of supernatant was added to the 1-ml bath (pH 7.4) and maintained for 2 h before contraction in response to EFS was measured.
Isolation of muscle and epithelial cells. Our methods for enzymatic isolation of muscle cell have been described previously (13) . Briefly, LES and esophageal muscle specimens are digested in HEPESbuffered physiological solution containing collagenase. At the end of the digestion period, the tissue is rinsed and then incubated in collagenase-free HEPES buffer. The cells dissociate freely in collagenase-free solution.
For enzymatic isolation of epithelial cells the esophageal mucosa was quickly rinsed in cold phosphate-buffered saline (PBS) solution (PBS, Sigma, St. Louis, MO) (pH 7.4) containing 0.01 M phosphate buffer, 0.0027 M KCl, and 0.13 M NaCl. After connective tissue was carefully removed under microscope, the esophageal mucosa was cut into squares and the squares were incubated in a trypsin-EDTA solution (Mediatech, Manassas, VA) for 15 min at 37°C in a shaking water bath set to agitate at 100 rpm with the epithelium facing downward. The epithelial cells were separated from the tissue by scraping away the overlaying tissue with a small forceps, and the remaining cells were pipetted multiple times to dissociate large cell clumps (2) . The tissue was transferred to a second petri dish containing a similar solution without trypsin and containing 5 g/ml soybean trypsin inhibitor. The cell suspension was then centrifuged at 250 g for 10 min. The cell pellet was resuspended in growth medium. Intact epithelial cells were sorted by flow cytometry obtaining a 90 -95% pure cell population as determined by visual examination. Alternatively, the epithelial cells were permeabilized with saponin (75 g/ml) for 3 min and incubated with a pan-cytokeratin antibody (H-240, Santa Cruz, catalog no. SC-15367) conjugated with magnet beads (Pierce, Rockford, IL, catalog no. 21352) for 15-30 min at 4°C, with gentle swirling every 10 min during incubation to keep the beads in suspension. Cytokeratin-containing cells were isolated by exposing the suspension to a magnetic field as previously reported (16, 24, 26, 32, 45, 64) .
The isolated epithelial cells were used for PAF measurements and for determination of TRPV1 mRNA and TRPV1 protein.
Measurement of CGRP and substance P. Esophageal tissue from the mucosal layer (100 mg) was homogenized in 2 ml of PBS (Sigma) (pH 7.4) containing 0.01 M phosphate buffer, 0.0027 M KCl, 0.137 M NaCl, and EDTA 0.18%. Homogenization was achieved with three 10-to 20-s bursts with a Tissue Tearor (BioSpec). The homogenate was centrifuged at 2,000 g and 4°C for 20 min. An aliquot of homogenate was taken for protein determination. The homogenate supernatant or the mucosal sac supernatant was frozen in liquid nitrogen for later use. The concentrations of CGRP and substance P present in the homogenate supernatant or in the mucosal sac supernatant were measured with enzyme immunoassay kits from Cayman Chemical (Ann Arbor, MI).
Measurement of PAF. PAF was extracted from tissues by a modification of the method of Bligh and Dyer (9) . Esophageal tissue (100 mg of mucosa) was homogenized in 2 ml of methanol. One milliliter of homogenate was transferred to a tube containing 0.5 ml of chloroform, 1 ml of methanol, and 0.4 ml of H2O for a final ratio of 1:2:0.8 chloroform:methanol:H2O (vol/vol/vol). The mixture was vortexed, left at room temperature for 1 h, and then centrifuged (5,000 g, 5 min). The supernatant was transferred to another glass tube, and the pellet was reextracted with 3.8 ml of the chloroform:methanol:H2O solution. The mixture was centrifuged again, and the two supernatants were combined. Two milliliters of chloroform and two milliliters of 1 M NaCl were added, and the phases were separated by centrifugation (5,000 g, 5 min). The upper phase was aspirated and discarded, and the lower phase was washed once with 4 ml of 1 M NaCl:methanol (9:1 vol/vol). Samples of this washed chloroform phase were dried under nitrogen and stored at Ϫ20°C. Measurement of PAF was performed within 72 h of extraction.
Measurement of tissue levels of PAF or of PAF in the mucosal sac supernatant were made with the PAF-[ 3 H] scintillation proximity assay system (TRK 990; Amersham International, Amersham, UK). The scintillation proximity assay is a sensitive assay system that uses microscopic beads containing scintillant that emit light when radiolabeled molecules of interest bind to the surface of the bead.
RT-PCR. Total RNA was isolated by TRIzol reagent (Invitrogen) from esophageal mucosa. Two micrograms of total RNA was reversely transcribed and then subjected to PCR by using a SuperScript First-Strand Synthesis System for RT-PCR kit (Invitrogen).
Primers for TRPV1 mRNA were sense: GACTTCAAGGCT-GTCTTCATCATCC and antisense: CAGGGAGAAGCTCAGGGT-GCGC. The primers were derived from conserved regions of mRNA sequences of human, rat, dog, mouse, guinea pig, and rabbit. We confirmed, through the BLAST database, that the primers were specific for TRPV1. Reactions were carried out in a PTC-100 Programmable Thermal Controller (MJ Research, Waltham, MA) for one cycle at 94°C for 5 min, followed by 40 cycles at 94°C for 1 min, 62°C for 1 min, and 72°C for 1 min.
Western blot analysis. Isolated epithelial cells were mixed with 2% SDS loading buffer containing 62.5 mM Tris ⅐ HCl (pH 6.8), 5% 2-mercaptoethanol, 0.002% bromphenol blue, and 10% glycerol and boiled for 5 min. After these samples were subjected to SDS-PAGE (100 V, 150 min) with an acrylamide concentration of 10% in the separating gel, the separated proteins were electrophoretically transferred to a nitrocellulose (NC) membrane (Bio-Rad, Melville, NY) at 100 V for 1 h. Transfer of proteins to the NC membrane was confirmed with Ponceau S staining reagent (Sigma). To block nonspecific binding, the NC membrane was incubated in 5% nonfat dry milk in PBS for 60 min, followed by three rinses in milk-free buffer. Samples were incubated with anti-TRPV1 antibody (1:4,000; Millipore, Billerica, MA) for 1 h with shaking, followed by three washes with antibody-free buffer. This was followed by a 60-min incubation in HRP-conjugated goat anti-rabbit antibody (Amersham, Arlington Heights, IL). Detection was achieved with an enhanced chemiluminescence agent (Amersham). Molecular weight was estimated by comparison of sample bands with prestained molecular weight marker (Bio-Rad, Melville, NY).
Protein determination. The homogenates of esophageal tissues were solubilized by addition of 6 ml of 0.1 N NaOH and heating the sample at 80°C for 30 min. The amount of protein present was determined by colorimetric analysis (Bio-Rad) according to the method of Bradford (11) .
Materials and reagents. (Ϯ)-(3-(N-octadecylcarbamoyl)-2-methoxy)propyl-(2-thiazolioethyl) phosphate (CV3988) was purchased from Biomol (Plymouth Meeting, Pennsylvania), and 5Ј-iodoresiniferatoxin (IRTX) was purchased from LC Laboratories (Woburn, MA). All other reagents were purchased from Sigma-Aldrich.
Statistical analysis. Data are expressed as means Ϯ SE. Statistical differences between means were determined by Student's t-test. Differences between multiple groups were tested with analysis of variance (ANOVA) for repeated measures and checked for significance with Scheffé's F-test.
RESULTS
To test whether the TRPV1 receptor may be the initial mediator of acid-induced inflammation in the cat esophagus, a tubular segment of normal esophageal mucosa was removed and tied at both ends to form a mucosal sac (20) 
Substance P levels increased 6-fold in mucosal tissue and in supernatant in response to HCl (Fig. 1) , while CGRP levels increased 200 times in the mucosa and 10 times in the supernatant (Fig. 2) . The HCl-induced increases in substance P and CGRP in mucosa and in supernatant were abolished when the TRPV1 receptor antagonist IRTX (10 Ϫ5 M) was added inside the mucosal sac, or when the neural toxin tetrodotoxin (TTX, 10 Ϫ6 M) was added inside the sac and to the supernatant, suggesting that TRPV1-induced release of substance P and CGRP was mediated through intrinsic neurons.
To confirm the presence of intrinsic neurons in mucosal tissue, histological sections of esophagus were immunostained to detect CGRP or substance P (Fig. 3) . CGRP immunoreactivity was localized in ganglion cells in the myenteric and submucosal plexus. In general, the immunoreactivity was low level and distributed throughout the cytoplasm, although occasional cells had intense levels of CGRP immunoreactivity. Substance P immunoreactivity was detected in scattered small neurons and fibers, mainly in the submucosal plexus. In addition, fine substance P-immunoreactive fibrils were distributed in the submucosa, but occasional longer and somewhat tortuous fibers (probably axons) were identified.
To establish a functional role of TRPV1 receptors, we examined contraction of esophageal circular muscle strips in Fig. 1 . When in vitro mucosa is exposed to HCl for 3 h, substance P levels increase 6 times in the mucosa and in the supernatant compared with control (pH 7.4) (*P Ͻ 0.05 ANOVA). The HCl-induced increase in substance P is abolished by the transient receptor potential channel vanilloid-1 (TRPV1) receptor antagonist 5Ј-iodoresiniferatoxin (IRTX) and by the neural blocker tetrodotoxin (TTX) both in the mucosa and in the supernatant ( # P Ͻ 0.05 ANOVA). Bars represent means Ϯ SE of mucosal tissue from 3 animals. response to EFS. EFS-induced contraction was almost abolished by incubation in the supernatant of HCl-filled (Fig. 4) or capsaicin (10 Ϫ6 M)-filled ( Fig. 5 ) mucosal sac. This supernatant-induced inhibition did not occur when the TRPV1 antagonist IRTX was present inside the mucosal sac, confirming the presence of functional capsaicin-sensitive TRPV1 receptors in the mucosal wall.
The reduction in contraction caused by supernatant of capsaicin-filled sac was almost abolished by preexposure of the muscle to the PAF receptor antagonist CV9388 (10 Ϫ6 M) (Fig. 6 ). This is consistent with release of PAF by mucosa in response to activation of TRPV1 by capsaicin and indicates that PAF is a major inflammatory mediator affecting circular muscle contraction. Measurements of PAF in mucosa tissue and in mucosa supernatant confirmed that PAF levels increased four to five times in the HCl-filled mucosal sac and in its supernatant compared with control (Krebs buffer-filled mucosal sac at pH 7.4) (Fig. 7) . The HCl-induced increase in PAF was abolished by the TRPV1 receptor antagonist IRTX. The increase in PAF levels in mucosa and supernatant, however, was not affected by neural block with TTX, indicating that production of PAF required no axonal conductance and most likely originated from the esophageal epithelium, consistent with the demonstrated presence of TRPV1 in nonneural cells such as keratinocytes of the epidermis (57, 58) , the human keratinocyte cell line HaCat (57), the human bronchial epithelial cell line BEAS-2B (65), bladder urothelium and smooth muscle (7, 8) , liver (51), polymorphonuclear granulocytes (30), and macrophages (17) .
The presence of TRPV1 receptor mRNA in esophageal mucosa was examined by RT-PCR (Fig. 8A ). Primers were derived from conserved regions of mRNA sequences of human, rat, dog, mouse, guinea pig, and rabbit. The BLAST database confirmed that the primers were specific for TRPV1. Fig. 2 . When in vitro mucosa is exposed to HCl for 3 h, calcitonin gene-related peptide (CGRP) levels increase 200 times in the mucosa and 10 times in the supernatant compared with control (pH 7.4) (*P Ͻ 0.05 ANOVA). The HCl-induced increase in CGRP is abolished by the TRPV1 receptor antagonist IRTX and by the neural blocker TTX both in the mucosa and in the supernatant ( # P Ͻ 0.05 ANOVA). Bars represent means Ϯ SE of mucosal tissue from 3 animals.
Fig. 3. Histological sections of esophagus immunostained to detect CGRP (A, B) or substance P (C, D).
Immunoreactivity was detected with secondary antibody tagged with horseradish peroxidase-conjugated polymer and diaminobenzidine (brown precipitate). Sections were counterstained with hematoxylin (blue) to depict unlabeled cells. A and B: CGRP immunoreactivity was localized in ganglion cells (note nucleoli). In general, in the submucous plexus the immunoreactivity was low level and distributed throughout the cytoplasm (arrows), although occasional cells had intense levels of CGRP immunoreactivity (double-headed arrow, B). C and D: substance P immunoreactivity was easily detected in scattered small neurons and fibers of the submucous plexus. In addition, fine substance P-immunoreactive fibrils were distributed in the submucosa, but occasional longer and somewhat tortuous fibers (probably axons) were identified (doubleheaded arrow, D).
The band produced with these primers was sequenced, obtaining the sequence of cat TRPV1 with 95% homology to human TRPV1. To demonstrate the expression of TRPV1 receptor mRNA in nonneural cells, esophageal epithelial cells were enzymatically isolated and sorted by flow cytometry, and a 90 -95% pure cell preparation was obtained. RT-PCR confirmed the presence of TRPV1 receptor mRNA in these cat esophageal epithelial cells (Fig. 8A) .
To confirm the presence of TRPV1 protein in epithelial cells, Western blot analysis was performed in epithelial cells isolated by a different method. Epithelial cells were immunoprecipitated with an epithelial cell-selective pan-cytokeratin antibody conjugated with magnetic beads and were isolated by exposing the suspension to a magnetic field as previously reported (16, 24, 26, 32, 45, 64) . A 150-kDa band was immunoblotted with a TRPV1 antibody, confirming the presence of TRPV1 receptors in these cat esophageal epithelial cells (Fig. 8B) . Figure 9 shows that isolated epithelial cells produced PAF in response to HCl, and the response was abolished by IRTX, supporting the presence of HCl-sensitive TRPV1 receptors in these cells.
To further examine whether HCl-induced release of PAF by epithelial cells may affect production or release of substance P or CGRP by mucosal neurons, HCl-filled mucosal sac was incubated in oxygenated Krebs solution at 37°C for 3 h in the presence of the PAF receptor antagonist CV9388 (10 Ϫ6 M). CV9388 had no effect on substance P or CGRP concentration in the mucosal tissue or in the supernatant, indicating that HCl-induced production of substance P or CGRP by the mucosa is not affected by PAF (Figs. 10 and 11) .
We conclude that HCl-induced activation of TRPV1 receptors in esophageal mucosa results in release of substance P and CGRP from intrinsic neurons and release of PAF from epithelial cells (Fig. 9) . Epithelial cells contain TRPV1 receptors and release PAF when stimulated by HCl.
DISCUSSION
Disorders of esophageal motor function and LES competence, for instance, gastroesophageal reflux disease, affect more than 1 in 10 adults over 40 yr and 1 in 4 adults over 60 yr of age, but the mechanism responsible for the initiation of acid-induced damage in gastroesophageal reflux disease has not been elucidated. The recently demonstrated presence of acid-sensitive TRPV1 receptors (41) in sensory nerve fibers and in epithelial cells of esophageal mucosa provides a conceptually straightforward mechanism to understand the onset of inflammation.
TRPV1 is a nonselective cation channel that has been found in sensory nerves and is activated by capsaicin, heat, protons, and lipid mediators (14, 63) Activation of TRPV1 stimulates the release of substance P and CGRP (65, 66) , evoking the sensation of burning pain and, perhaps, inducing neurogenic inflammation (28, 38, 43, 47) . TRPV1 may play a role in heartburn, because capsaicin injection into the esophageal wall produces significant chest pain and heartburn in healthy volunteers (4) and TRPV1 immunoreactive nerve fibers are increased in patients with erosive (41) and nonerosive (5) . This is consistent with release of PAF by mucosa in response to activation of TRPV1 by capsaicin and suggests that PAF may be the inflammatory mediator most responsible for impairment of EFS-induced (i.e., neurally induced) contraction of circular muscle. Data represent means Ϯ SE of muscle strips from 3 animals.
esophagitis. Increased acid exposure is associated with an increase in TRPV1 immunoreactive nerve fibers in nonerosive esophagitis (5) .
Esophageal circular muscle exhibits no tone and contracts in response to electrical field (i.e., neural) stimulation that causes release of ACh from intramural neurons (3, 12) . We previously reported (21) in an in vivo cat model of esophagitis induced by repeated esophageal perfusion with 0.1 N HCl (45 min for 3 days) that contraction of esophageal circular muscle strips in response to electrical stimulation is reduced because of decreased release of ACh from cholinergic neurons. We have shown (20) that incubation in supernatant of mucosa exposed to HCl (but not direct incubation in HCl) almost abolished the circular muscle response to electrical stimulation, indicating the presence of inflammatory mediators released by the mucosa in response to acid. We have demonstrated that esophageal mucosa exposed to acid releases PAF, which inhibits circular muscle contraction by inhibiting ACh release in response to electrical stimulation (21) and by inducing sequential production of IL-6 and H 2 O 2 in the circular muscle layer (18, 19) that, similar to PAF, inhibit ACh release (21) .
In the present investigation we confirm that supernatant of the HCl-filled mucosal sac reduced the amplitude of esophageal contraction in response to EFS, as previously reported. We also show that the reduction in contraction is associated with formation of PAF, substance P, and CGRP in the mucosa. Diffusion of HCl across the mucosa is unlikely to be responsible for the reduction in contraction, because the supernatant remained at pH 7.4 throughout the experiment. Similarly, diffusion of capsaicin across the mucosa is unlikely to play a role in reducing the contraction, because capsaicin contracts circular muscle (27, 29, 52) , the supernatant of the capsaicinfilled sac inhibited circular muscle contraction, and, in addition, the contraction was almost completely restored by a PAF antagonist. PAF, however, is produced with substance P and CGRP; Fig. 7 . When in vitro mucosa is exposed to HCl for 3 h, PAF levels increase 4 -5 times in the mucosa and in the supernatant compared with control (pH 7.4) (*P Ͻ 0.05 ANOVA). The HCl-induced increase in PAF is abolished by the TRPV1 receptor antagonist IRTX ( # P Ͻ 0.05 ANOVA) and not affected by the neural blocker TTX both in the mucosa and in the supernatant, indicating that production of PAF does not involve axonal conductance. Data represent means Ϯ SE of mucosal tissue from 3 animals. Fig. 8 . A: to demonstrate the presence of TRPV1 receptor mRNA in nonneural cells, esophageal epithelial cells were enzymatically isolated and sorted by flow cytometry. Primers were derived from conserved regions of mRNA sequences of human, rat, dog, mouse, guinea pig, and rabbit. RT-PCR confirmed the presence of TRPV1 receptor mRNA in these cat esophageal epithelial cells. B: to perform Western blot analysis, epithelial cells were immunoprecipitated with an epithelial cell-selective pan-cytokeratin antibody conjugated with magnetic beads and were isolated by exposing the suspension to a magnetic field as specified by the manufacturer. A 150-kDa band was immunoblotted with a TRPV1 antibody, confirming the presence of TRPV1 receptors in these cat esophageal epithelial cells. thus it is surprising that the PAF antagonist by itself restored the reduction in contraction induced by the supernatant. This result may be explained by considering that substance P and CGRP have opposite effects on contraction of esophageal circular muscle. Substance P contracts esophageal muscle (4, 9 -11) , and CGRP inhibits contraction (14, 22) . Thus it is likely that the effects of substance P and CGRP on esophageal muscle contraction neutralize each other and, as a result, PAF is responsible for the net reduction in muscle contraction by inhibiting ACh release from cholinergic neurons (3, 12) .
The PAF production is linked to TRPV1 receptors, because the TRPV1 antagonist IRTX significantly reduced PAF production and supernatant-induced inhibition of esophageal contraction. This finding supports the idea that the initial steps leading to development of esophageal inflammation may be mediated by activation of TRPV1. TRPV1-mediated production of substance P and CGRP was blocked by TTX, consistent with neural release of these mediators. PAF production, however, was not affected by TTX. We have demonstrated that acid induces PAF production by epithelial cells isolated by cell sorting after enzymatic isolation from the mucosal layer. TRPV1 receptors are present in these isolated epithelial cells, because HCl-induced PAF production is blocked by IRTX.
Although TRPV1-associated "neurogenic inflammation" has been examined in several systems, particularly in the airways and to a lesser extent in the digestive tract (28) , most published research has focused on TRPV1-mediated release of substance P through neural mechanisms (28, 38, 43, 47) . Both substance P-and CGRP-containing neural cells have been demonstrated in the submucous plexus and a lamina propria subplexus of the intestine (10, 25, 31, 49, 50, 53, 56, 59, 62) , but some controversy has been raised about the existence of neural cell bodies in the esophageal submucosa. Substance P-and CGRPcontaining neural cells, however, have been demonstrated in the human esophagus submucous plexus (55) and epithelium (54) . Our preparation indicates that 3-h exposure to a moderately low pH (5.8) results in additional synthesis and release of substance P and CGRP by intrinsic neurons in the experimental preparation. Both synthesis and release depend on activation of TRPV1 receptors, because both are abolished by the vanilloid receptor antagonist IRTX. Axonal conductance is involved in the release into the supernatant, because it is TTX sensitive. Mucosal content is also affected by TTX, as it may reflect release of the peptides within the tissue before diffusion into the supernatant. Peptide content in neurons or nerve endings may not be reflected in these measurements, because centrifugation separates particulate matter from the tissue supernatant, where peptide content is measured.
There is some controversy whether submucous cell bodies are present in the esophagus, perhaps because the submucous plexus Fig. 10 . When in vitro mucosa is exposed to HCl for 3 h, substance P levels significantly increase in the mucosa and in the supernatant compared with control (pH 7.4) (*P Ͻ 0.05 ANOVA). The HCl-induced increase in substance P was not affected by the PAF receptor antagonist CV3988. Bars represent means Ϯ SE of mucosal tissue from 3 animals. Fig. 11 . When in vitro mucosa is exposed to HCl for 3 h, CGRP levels significantly increase in the mucosa and in the supernatant compared with control (pH 7.4) (*P Ͻ 0.05 ANOVA). The HCl-induced increase in CGRP was not affected by the PAF receptor antagonist CV3988. Bars represent means Ϯ SE of mucosal tissue from 3 animals. is less developed than the myenteric plexus and several serial sections may be examined without encountering neural somata (55) . In the human esophagus, however, CGRP, galanin, substance P, and VIP-like immunoreactivity occurred abundantly in terminations and somata of the submucous neurons (55) . In the cat we find substance P and CGRP immunoreactivity localized in ganglion cells in the myenteric and submucosal plexus. In general, CGRP immunoreactivity was low level and distributed throughout the cytoplasm, and substance P immunoreactivity was detected in scattered small neurons and fibers, mainly in the submucosal plexus. These findings are compatible with synthesis of neurotransmitter by submucous neural somata present in the preparation and release from nerve endings through TTX-sensitive axonal conductance.
A link between TRPV1 and PAF has not been reported in the literature for any part of the gut, but direct TRPV1-induced formation of PAF is supported by the fact that isolated cat esophageal epithelial cells contain TRPV1 receptor mRNA, express the protein, and release PAF when exposed to low pH, suggesting that the epithelial cells themselves are responsible for production of PAF and initiation of the inflammatory processes.
The presence of TRPV1 receptors in esophageal epithelial cells is consistent with its presence in other nonneural cells, such as keratinocytes of the epidermis (57, 58) , the human keratinocyte cell line HaCat (57), the human bronchial epithelial cell line BEAS-2B (65), bladder urothelium and smooth muscle (7, 8) , liver (51), polymorphonuclear granulocytes (30) , and macrophages (17) .
Because TRPV1 receptors are present in esophageal epithelial cells and induce PAF release by these cells, production of substance P/CGRP by submucous neurons could conceivably be affected/promoted by PAF formed in the epithelial layer and diffusing to intrinsic neurons. The production of substance P and CGRP in the mucosa, however, was not affected by the PAF receptor antagonist CV3988, indicating that production of substance P and CGRP does not depend on PAF.
In conclusion, the data are consistent with the presence of TRPV1 receptors on intrinsic neurons in esophageal submucosa. In addition, TRPV1 receptors are present on esophageal epithelial cells and directly linked to production of PAF, causing the initial event responsible for a subsequent cascade of inflammatory mediators in circular muscle (18, 19) . These and other data (48) suggest that PAF may be an important inflammatory mediator contributing to induction of esophagitis.
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